CHF 189.00

Drug Targets in Kinetoplastid Parasites

Inglese · Copertina rigida

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

If viewed globally, the parasitic diseases pose an increasing threat to human health and welfare. The diseases caused by kinetoplastid protozoan parasites like Leishmania and Trypanosoma continue as a cause of suffering for many millions of people in both tropical and subtropical regions of the world. Leishmania species are found throughout Latin America, Africa and Asia. Trypanosoma cruzi that cause Chagas' disease is endemic in Latin America, while members of Trypanosoma brucei group are found in sub-Saharan Africa. Although the past two decades has witnessed commendable research efforts and technical advances in our understanding of the biochemistry, molecular and cell biology of these pathogens, the dreaded protozoal diseases caused by these organisms threaten mankind. Therapeutic tools for the treatment of most parasitic diseases are extremely limited. The development of parasites resistant to many of the available drugs is also responsible for the depressing picture of disease persistence and death. Development of commercially available vaccines is still far from reality, though research and trial programs continue.

Riassunto

If viewed globally, the parasitic diseases pose an increasing threat to human health and welfare. The diseases caused by kinetoplastid protozoan parasites like Leishmania and Trypanosoma continue as a cause of suffering for many millions of people in both tropical and subtropical regions of the world. Leishmania species are found throughout Latin America, Africa and Asia. Trypanosoma cruzi that cause Chagas’ disease is endemic in Latin America, while members of Trypanosoma brucei group are found in sub-Saharan Africa. Although the past two decades has witnessed commendable research efforts and technical advances in our understanding of the biochemistry, molecular and cell biology of these pathogens, the dreaded protozoal diseases caused by these organisms threaten mankind. Therapeutic tools for the treatment of most parasitic diseases are extremely limited. The development of parasites resistant to many of the available drugs is also responsible for the depressing picture of disease persistence and death. Development of commercially available vaccines is still far from reality, though research and trial programs continue.

Dettagli sul prodotto

Con la collaborazione di Hemanta K. Majumder (Editore), Hemant K Majumder (Editore), Hemanta K Majumder (Editore)
Autori H. K. Majumder
Editore Springer, Berlin
 
Contenuto Libro
Forma del prodotto Copertina rigida
Data pubblicazione 15.02.2008
Categoria Scienze naturali, medicina, informatica, tecnica > Biologia > Microbiologia
 
EAN 9780387775692
ISBN 978-0-387-77569-2
Numero di pagine 158
Illustrazioni XX, 158 p. 45 illus., 1 illus. in color.
Altezza (della confezione) 24.8 cm
Peso (della confezione) 462 g
 
Serie Advances in Experimental Medicine and Biology > 625
Advances in Experimental Medicine and Biology
Categorie Protein, B, death, treatment, Resistance, Development, Genome, Diseases, METABOLISM, Health, parasite, proteins, Biomedical and Life Sciences, Parasitology, parasites
 

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.